menu bioanalytique
liste des dosages
Varier selon les espèces, l’utilisation prévue et les domaines thérapeutiques.
La liste ci-dessous continue de croître et d’évoluer. Cette liste illustre les méthodes de dosage que nous proposons et n’est en aucun cas notre pleine capacité.
Analyte(s) | Range | Validation Level | Anticoagulant | Species | Matrix | Intended Use | Therapeutic Area |
---|---|---|---|---|---|---|---|
Ritonavir | 10.0-10,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Immunology |
Ondansetron | 0.250 – 250 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Oncology |
Melatonin | 1.00-1,000 | Full Regulatory | NA | Human | Saliva | Pharmacokinetics; Biomarker | Neuroscience and Pain; Endocrine |
Simvastatin | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Simvastatin Hydroxy Acid | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Fentanyl | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Morphine | 0.200-50.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Oxycodone | 0.200-50.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Morphine-6-Gluc | 0.400-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ketoprofen | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma (H+) | Pharmacokinetics | Neuroscience and Pain |
(R)-Methadone | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
(S)-Methadone | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Nordiazepam | 0.500-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Clorazepate | 0.500-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Diclofenac | 0.100-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Atorvastatin | 50-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
2-Hydroxyatorvastatin | 20-20,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
4-Hydroxyatorvastatin | 20-20,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Hydrocodone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Hydromorphone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Norhydrocodone | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Acetaminophen | 50.0-50,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Rosuvastatin | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Pravastatin | 0.100-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
(R)-Amphetamine | 0.200-200 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
(S)-Amphetamine | 0.200-200 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ropivacaine | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma (UF) | Pharmacokinetics | Neuroscience and Pain |
Ropivacaine | 1.00-1,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Fentanyl | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Ethinyl Estradiol | 7.50-7,500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Endocrine |
Norethindrone | 100-100,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Endocrine |
1MX | 100-100,000 | Full Regulatory | NA | Human | Urine (2Xcs) | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
AFMU | 100-100,000 | Full Regulatory | NA | Human | Urine (2Xcs) | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Isradipine | 0.100- 100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Metformin | 5.00-5,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic |
Anti-Insulin Ab | 100 – 1,000 | Full Regulatory | NA | Human | Serum | Pharmacokinetics | Cardiometabolic; Endocrine |
Midazolam | 0.1-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
1-OH Midazolam | 0.1-100 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Buproprion | 0.5-500 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
OH-Buproprion | 1-1000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Neuroscience and Pain |
Tolbutamide | 200-100,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
4-OH Tolbutamide | 2-1000 | Cardiometabolic | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Dextromethorphan | 0.1-50 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Dextrophan | 0.1-50 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Omeprazole | 2-1000 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
5-OH Omeprazole | 1-500 | Neuroscience and Pain | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Repaglinide | 0.0500-50 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
3-OH Repaglinide Diastereomer A | 0.0109-10.9 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
3-OH Repaglinide Diastereomer B | 0.0141-14.1 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics; Drug-Drug Interaction | Cardiometabolic |
Bupivacaine | 2-2,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Neuroscience and Pain |
Erythromycin | 0.0500 - 10.0 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Antimicrobial |
Insulin Lispro | 10.0 - 400 µU/mL | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Cardiometabolic; Endocrine |
Moxifloxacin | 10.0 - 10,000 | Full Regulatory | K2 EDTA | Human | Plasma | Pharmacokinetics | Antimicrobial |
Analyte(s) | Range | Validation Level | Anticoagulant | Species | Matrix | Intended Use | Therapeutic Area |
---|---|---|---|---|---|---|---|
bST (bovine somatotropin) | 1.25-50 ng/mL | Research | NA | Bovine | Serum | Biomarker | Endocrine; Animal Health |
CA 19-9 | 200-0.274 U/mL | Research | NA | Human | Serum | Biomarker | Oncology |
CAIX | 500-31.3 pg/mL | Research | NA | Human | Serum | Biomarker | Oncology |
C-peptide | 19.1 - 1170 pM | Research | K2EDTA | Porcine | Plasma | Biomarker | Cardiometabolic; Endocrine |
CRP | 27.6-49608 pg/mL | Research | NA | Human | Serum | Biomarker | Cardiometabolic; Oncology; Immunology |
Haptoglobin | 0 - 50 µg/mL | Research | NA | Bovine | Serum | Biomarker | Cardiometabolic; Immunology |
IFN-alpha, IL-1 beta, IL-10, IL-12p70, IL-2, IL-4, IL-5, and TNF-alpha | Various | Qualified | NA | Mouse | Serum | Biomarker | Immunology |
IGF1 (insulin-like growth factor 1) | 0.312-20 ng/mL | Research | NA | Bovine | Serum | Biomarker | Endocrine |
IL-1 beta, IL-2, IL-12p70, TNF-alpha | Various | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
IL-12 | 30-10,000 pg/mL | Research | NA | Canine | Serum | Biomarker | Immunology |
IL-17 | 9.32-3653 pg/mL | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
IL-6 | 1.58-488 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
IL-8 | 1.13-375 pg/mL | Screening | NA | Bovine | Serum | Biomarker | Immunology |
Lipopolysaccharide Binding Protein | NA | Research | NA | Bovine | Serum | Biomarker | Immunology |
Myeloperoxidase | 0.312-20 ng/mL | Research | NA | Bovine | Serum | Biomarker | Cardiometabolic; Immunology |
Serum Amyloid A | 54.1-137,972 pg/mL | Research | NA | Bovine | Serum | Biomarker | Immunology |
TGF beta1 | 30-2000 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
TNF alpha | 0.69-248 pg/mL | Research | NA | Human | Serum | Biomarker | Immunology |
TNF alpha | NA | Research | K2EDTA | Human | Plasma | Biomarker | Immunology |
VEGF | 7.70-784 pg/mL | Research | NA | Human | Serum | Biomarker | |
Caffeine | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain | |
Theobromine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
Paraxanthine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
Glutamine | NA | Research | K2EDTA | Human | Plasma | LC/MS Drug-Drug Interaction | Neuroscience and pain |
glutamate | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
pyroglutamic acid | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
glutamic acid | NA | Research | K2EDTA | Human | Plasma | LC/MS | Neuroscience and pain |
Glutathione | 200-200,000 ng/mL | Research | NA | Human | Serum | LC/MS | Cardiometabolic; Immunology |
Glutathione disulfide | NA | Research | NA | Human | Serum | LC/MS | Cardiometabolic; Immunology |
N-Acetyl-L-Cysteine | 10-1000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Glutathione | 200-20,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Cysteine | 10,000-1,000,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Homocysteine | 200-20,000 ng/mL | Research | NA | Human | Plasma | LC/MS | Cardiometabolic; Immunology |
Paclitaxel | 1-1,000 ng/mL | Research | K2EDTA | Human | Plasma | LC/MS | Oncology |